Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Basware BAS1V Jun 18, 2021 37.25 -0.53   
 BBS-Bioactive Bone Substitutes BONEH Jun 18, 2021 3.07 +5.14   
 Bilot Plc BILOT Jun 18, 2021 7.22 0.00   
 Biohit B BIOBV Jun 18, 2021 2.05 -1.44   
 Bittium BITTI Jun 18, 2021 6.29 +1.13   
 Boreo BOREO Jun 18, 2021 44.40 +0.91   
 CapMan CAPMAN Jun 18, 2021 2.80 +0.90   
 Cargotec CGCBV Jun 18, 2021 44.52 +0.59   
 Caverion CAV1V Jun 18, 2021 6.79 -1.24   
 Citycon CTY1S Jun 18, 2021 7.27 +0.21   
 Componenta CTH1V Jun 18, 2021 3.28 -1.62   
 Consti Plc CONSTI Jun 18, 2021 12.50 0.00   
 Detection Technology DETEC Jun 18, 2021 29.50 -1.67   
 Digia DIGIA Jun 18, 2021 7.50 -1.19   
 Digitalist Group DIGIGR Jun 18, 2021 0.05 -3.69   
 Dovre Group DOV1V Jun 18, 2021 0.74 +4.79   
 EAB Group EAB Jun 18, 2021 3.28 -2.96   
 Eezy Oyj EEZY Jun 18, 2021 5.90 0.00   
 Efecte PLC EFECTE Jun 18, 2021 15.20 +0.66   
 Elecster A ELEAV Jun 18, 2021 9.62 +0.84   
 Elisa ELISA Jun 18, 2021 50.96 -0.89   
 Endomines ENDOM Jun 18, 2021 0.25 -1.55   
 Enedo ENEDO Jun 18, 2021 0.46 -0.87   
 Enento Group ENENTO Jun 18, 2021 33.50 0.00   
 eQ EQV1V Jun 18, 2021 24.05 +2.56   
 Ericsson B ERIBR Jun 18, 2021 10.55 -2.24   
 Etteplan ETTE Jun 18, 2021 17.00 0.00   
 Evli Pankki EVLI Jun 18, 2021 18.60 0.00   
 Exel Composites EXL1V Jun 18, 2021 10.04 -0.59   
 F-Secure FSC1V Jun 18, 2021 3.90 -5.68   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK